We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties. You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies. In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's Why Investors Should Hold on to MetLife Stock Right Now
Read MoreHide Full Article
MetLife, Inc. (MET - Free Report) gains from higher premiums, cost-cutting efforts, partnerships, acquisitions and steady cash balance.
MetLife’s Zacks Rank & Price Performance
MetLife carries a Zacks Rank #3 (Hold) at present.
The stock has gained 8% in the past year compared with the industry’s 4% growth.
Image Source: Zacks Investment Research
MET’s Rising Estimates
The Zacks Consensus Estimate for MetLife’s 2025 earnings is pegged at $9.60 per share, which indicates an improvement of 18.4% from the 2024 figure. The consensus mark for revenues is $75.6 billion, implying a rise of 3.5% from the 2024 figure.
The consensus mark for 2026 earnings is pegged at $10.52 per share, indicating an improvement of 9.7% from the 2025 estimate. The same for revenues is $78.1 billion, indicating a 3.3% increase from the 2025 estimate.
MET’s Solid Return on Equity
Return on equity in the trailing 12 months is currently 20.4%, which is higher than the industry’s average of 14.4%. This substantiates the company’s efficiency in utilizing shareholders’ funds.
MetLife’s Business Tailwinds
MetLife has seen a steady recovery in its premiums, which are a significant contributor to the revenues of any insurer. In the Group Benefits segment, premiums grew 4% year over year in 2024. Additionally, the EMEA and Latin America segments have delivered strong premium growth, further bolstering the company’s revenue base.
The company’s emphasis on streamlining operations, strategic acquisitions and collaborations is expected to support sustainable growth. MetLife has expanded its footprint in high-demand areas like vision care and pet insurance through the acquisitions of Versant Health and PetFirst, respectively. Partnerships with firms like Aura and Nayya have further enhanced its benefits portfolio. MetLife Investment Management recently agreed to acquire PineBridge Investments and Mesirow Financial, growing its assets under management.
In December 2024, MetLife announced its partnership with Workday, which will integrate the former’s benefits offerings with the latter’s analytics-driven platform. MET has reduced volatility by divesting capital-intensive operations and prioritizing investments in high-growth areas.
Cost-saving initiatives have driven significant operational efficiency at MetLife. Between 2015 and 2020, the company improved its direct expense ratio by 230 basis points. This trend has persisted, with the direct expense ratio remaining below the guided 12.3% threshold in 2024. It now expects to reduce the direct expense ratio by another 100 basis points in the next five years. MET launched its New Frontier Strategy, which is expected to focus on expanding leadership in group benefits and retirement platform, growing its asset management business and international business.
MetLife’s robust liquidity position, evidenced by $20.1 billion in cash and cash equivalents as of Dec. 31, 2024, far exceeds its short-term debt of $119 million. It expects to generate free cash flow worth $25 billion in the next five years. This financial strength supports shareholder returns through share repurchases and dividend payouts. In April 2024, the company increased its dividend by 4.8%, further demonstrating its commitment to rewarding investors. Its dividend yield of 2.8% remains higher than the industry’s average of 2.5%.
The Zacks Consensus Estimate for ProAssurance’s bottom line for 2025 is pegged at 91 cents per share. The stock has witnessed two upward estimate revisions in the past 30 days with no movement in the opposite direction. PRA beat earnings estimates in each of the last four quarters, with an average surprise of 152.7%.
The consensus estimate for HCI Group’s 2025 earnings per share indicates 102.2% year-over-year growth to $14.98. It beat earnings estimates in each of the last four quarters, with an average surprise of 45.7%. The consensus mark for HCI’s current-year revenues signals a 17.5% increase from a year ago.
The Zacks Consensus Estimate for Palomar Holdings’ 2025 earnings per share implies 31.8% year-over-year growth to $6.71. It beat earnings estimates in each of the last four quarters, with an average surprise of 16.6%. The consensus mark for PLMR’s current-year revenues signals 38.9% growth from a year ago.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Here's Why Investors Should Hold on to MetLife Stock Right Now
MetLife, Inc. (MET - Free Report) gains from higher premiums, cost-cutting efforts, partnerships, acquisitions and steady cash balance.
MetLife’s Zacks Rank & Price Performance
MetLife carries a Zacks Rank #3 (Hold) at present.
The stock has gained 8% in the past year compared with the industry’s 4% growth.
Image Source: Zacks Investment Research
MET’s Rising Estimates
The Zacks Consensus Estimate for MetLife’s 2025 earnings is pegged at $9.60 per share, which indicates an improvement of 18.4% from the 2024 figure. The consensus mark for revenues is $75.6 billion, implying a rise of 3.5% from the 2024 figure.
The consensus mark for 2026 earnings is pegged at $10.52 per share, indicating an improvement of 9.7% from the 2025 estimate. The same for revenues is $78.1 billion, indicating a 3.3% increase from the 2025 estimate.
MET’s Solid Return on Equity
Return on equity in the trailing 12 months is currently 20.4%, which is higher than the industry’s average of 14.4%. This substantiates the company’s efficiency in utilizing shareholders’ funds.
MetLife’s Business Tailwinds
MetLife has seen a steady recovery in its premiums, which are a significant contributor to the revenues of any insurer. In the Group Benefits segment, premiums grew 4% year over year in 2024. Additionally, the EMEA and Latin America segments have delivered strong premium growth, further bolstering the company’s revenue base.
The company’s emphasis on streamlining operations, strategic acquisitions and collaborations is expected to support sustainable growth. MetLife has expanded its footprint in high-demand areas like vision care and pet insurance through the acquisitions of Versant Health and PetFirst, respectively. Partnerships with firms like Aura and Nayya have further enhanced its benefits portfolio. MetLife Investment Management recently agreed to acquire PineBridge Investments and Mesirow Financial, growing its assets under management.
In December 2024, MetLife announced its partnership with Workday, which will integrate the former’s benefits offerings with the latter’s analytics-driven platform. MET has reduced volatility by divesting capital-intensive operations and prioritizing investments in high-growth areas.
Cost-saving initiatives have driven significant operational efficiency at MetLife. Between 2015 and 2020, the company improved its direct expense ratio by 230 basis points. This trend has persisted, with the direct expense ratio remaining below the guided 12.3% threshold in 2024. It now expects to reduce the direct expense ratio by another 100 basis points in the next five years. MET launched its New Frontier Strategy, which is expected to focus on expanding leadership in group benefits and retirement platform, growing its asset management business and international business.
MetLife’s robust liquidity position, evidenced by $20.1 billion in cash and cash equivalents as of Dec. 31, 2024, far exceeds its short-term debt of $119 million. It expects to generate free cash flow worth $25 billion in the next five years. This financial strength supports shareholder returns through share repurchases and dividend payouts. In April 2024, the company increased its dividend by 4.8%, further demonstrating its commitment to rewarding investors. Its dividend yield of 2.8% remains higher than the industry’s average of 2.5%.
Key Picks
Some better-ranked players in the broader Finance space are ProAssurance Corporation (PRA - Free Report) , HCI Group, Inc. (HCI - Free Report) and Palomar Holdings, Inc. (PLMR - Free Report) , each presently sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for ProAssurance’s bottom line for 2025 is pegged at 91 cents per share. The stock has witnessed two upward estimate revisions in the past 30 days with no movement in the opposite direction. PRA beat earnings estimates in each of the last four quarters, with an average surprise of 152.7%.
The consensus estimate for HCI Group’s 2025 earnings per share indicates 102.2% year-over-year growth to $14.98. It beat earnings estimates in each of the last four quarters, with an average surprise of 45.7%. The consensus mark for HCI’s current-year revenues signals a 17.5% increase from a year ago.
The Zacks Consensus Estimate for Palomar Holdings’ 2025 earnings per share implies 31.8% year-over-year growth to $6.71. It beat earnings estimates in each of the last four quarters, with an average surprise of 16.6%. The consensus mark for PLMR’s current-year revenues signals 38.9% growth from a year ago.